[Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
D000636:Aminosalicylic Acids / Q000494:pharmacology; D003470:Culture Media; D003864:Depression, Chemical; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage* / Q000097:blood; D005000:Ethionamide / Q000494:pharmacology; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D009161:Mycobacterium / Q000187:drug effects* / Q000302:isolation & purification; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D012293:Rifampin / Q000008:administration & dosage* / Q000097:blood; D013307:Streptomycin / Q000494:pharmacology; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000097:blood / Q000188:drug therapy* / Q000382:microbiology
D000636:Aminosalicylic Acids; D003470:Culture Media; D004977:Ethambutol; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Issledovanie tuberkulostaticheskoĭ aktivnosti i kontsentra tsii v krovi novykh preparatov--rifampitsina i etambutola-ubol'nykh tuberkulezom legkikh.